Skip to content

Sugammadex Impurity 14

Sugammadex Impurity 14

Product Description
CAT No.
ALN-S029058
CAS No.
779318-36-4
Mol. F.
C54H84O36S6
Mol. Wt.
1501.6
Stock
Please Inquire
Smiles : O=C(O)CCSC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@@H](O)[C@@H](O)[C@H](O[C@@H]3CSCCC(O)=O)O4)O[C@@H]2CSCCC(O)=O)[C@H](O)[C@@H](O)[C@@H]1O[C@H]5O[C@H](CSCCC(O)=O)[C@@H](O[C@H]6O[C@H](CSCCC(O)=O)[C@@H](O[C@H]7O[C@H](CSCCC(O)=O)[C@@H]4[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)C(O)[C@H]5O
Inchi : InChI=1/C20H27N3O7S/c1-4-17-13(2)11-23(18(17)25)19(26)21-10-9-15-5-7-16(8-6-15)31(28,29)22-20(27)30-12-14(3)24/h5-8,14,24H,4,9-12H2,1-3H3,(H,21,26)(H,22,27)

Analytical method development and validation for the estimation of sugammadex

By Parekh, Hemangi; Chokshi, Parin; Mashru, RajashreenFrom Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.

Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay

By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H – From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.

Request For Quotation